Extramedullary plasma cytoma invol ving the skull base is rare. We desc ribe wha t we believe is the firs t rep orted case of recur rent multip le myeloma presenting as an isolated les ion in the central skull base in a patient with no evidence ofsys temic involvement. We discuss the patient's presentation, clinical cou rse, and treatm ent, and we review the relevant scientific literature.
Introduction
Plasma cell tumors represent 0.4 % of all head and neck malignancie s; they tend to occur in the sixth decade oflife, and they are more co mmo n in men than in wo men.1,2 These neopl asms are subclassi fied into thre e types along a clinical spectrum: mu ltipl e myelomas, solitary pl asma cytomas of bone, and ext ramedullary pla smacytomas/:' Extramedullary plasm acytomas acc ount for 3% of all pla sma cell tumors. '>Approximately 85% of these tum ors arise in the head and neck-primarily in the nasopharynx, nasal cavities, and paranasal sinuses. L6 ,8.9 Even so , only 50 cases of plasmacytoma of the nas al cavities and sinuses have been reported to date.LID Even more rarely reported location s of head/neck extramedullary plasmacytomas include the salivary glands, lacrim al glands, orbit, glottis, trachea, and thyroid gland. I Head/neck extr amedullary plasm acytom as are believed to origin ate in the mucosal linin g of the sinonasa l tract.P :" Monocl on al prolifer ations of plasm a cells without evidence of systemic disease are referred to as solitary extram edullar y pla sma cytomas. These osteo lytic soft-ti ssue masses are very tre atable, and they are associated with a 10-year sur vival rate of 70 %.'-4 Ho wever, solitary extra-medullary plasmacytom as have been rep orted to pro gre ss to multiple myeloma in as many as 30% of case s. 1,4.12-14 Mul tiple myeloma is a systemic process with an incidenc e of 4 per 100,000 popul ation .15 Unfortunatel y, when a solitary extram edullary plasmacytom a progresses to multiple myeloma, the prognosis is grave; a me an survival rate of only 2 to 3 years has been reported for such patients.' :"
Pla smacytomas involving the skull ba se are also rare.':'? Our review of individual case reports and a small series in the En glish-language literature found only 35 cases.' :"
Ten of these tumors involved the central skull base and were ame nable to transnasal biopsy. 1.8.9.15.18-22 In every case, howe ver, the plasm acytom a was either an isolated lesion or later p rogressed to multiple myeloma.
In thi s article, we present what to the best of our know ledg e is the first rep ort in the Engli sh-l anguage lite rature of a multiple myeloma recurrence presenting as a solitary central skull base plasm acytoma in the absence of other systemic manifestations. We do not know whether this lesion is biologically distinct fro m traditional extramedullar y plasm acytomas.
Case report
A 58-year-old woman presented to her physician with a 6-month history of slowly pro gre ssive headaches, facial numbness, and fac ial fullness, all on the right side. Her history was significant for Durie-S almon stage III multiple myeloma, which had been diagnosed and treated 4 years earlier. Bone marrow aspirates obt ained at that time demonstrated 50 % plasma cells. The pati ent had undergone chemoth erapy with vincristine, doxorubicin, busulfan, and cyclo phosphamide, and this had been follo wed by autologous peripheral stem ce ll tran spl ant ation. She had rem ain ed in remi ssion for more than 3 years .
Followin g a physical exa mination, magnetic reson ance imagin g (MRI) was obtained. The MRI dete cted a 26 x 22 x 19-mm mass in the right anterior petrous apex and clivus (figure I). The mass track ed along the middl e fossa dur a and extended into the right cavernous sinus and right sphenoid It was suspected that the skull base lesion might represent recurrent myeloma, but a tissue diagnosis was required for confirmation.The patient was referred to the otolaryngology serv ice for a biopsy. Her ENT history was significant for long-standin g bilateral tinnitus; she denied hearing loss, otorrhea, diplopia , vision loss, vertigo, and disequilibrium. A genera l head/neck examination and neurotologic investigation dem onst rated sensory abnormalities along the right anterior cheek, right nasal sidewall, right upper lip, and along the right superior alveolar ridge. Findin gs on the remainder of these examinations were normal.
Co mputed tomography (CT) was obtained to eva luate the bony anatomy of the anterior and lateral skull base. CT showed that the posterolateral wall of the right sphenoid sinus was eroded and that the lytic lesion had invaded the sinus (figure 2).
A neurotologic approac h to the anteriorpetrous apex/cl ivus was considered initially, but in view of the extension of the disease into the right sphenoid sinus, it was thought that a transnasal endosco pic approach would result in less morbidity. Endoscopy revealed that the mass was smooth and lobulated, and a sample was obtained from within the sinus (figure 3). Histologic analysis of the specimen identified a dense, atypic al plasmacytic infiltrate with vesicular chromatin and occasional small nucleol i-find- ings that are consis tent with multiple myeloma (figure 4, A). Immunologic staining showed diffuse expression of monoclonal kappa light chains ( figure 4, B) . After the patient recov ered from surgery, a system atic search was conducted to identify evidence of systemic myeloma. Findings on serum and urine electrophoresis, electrol yte, and renal function studies were negative, and a skeletal survey did not identify any osteo lytic lesions. A bone marrow biopsy did not reveal any abnormal plasma cells. The refore, the patient was diagnosed with recurrent myeloma of the skull base presenting as a solitary extramedull ary plasmacytoma.
The patient was offered positron-emi ssion tomography, but she refused. She underw ent external-beam radiotherapy to the skull base to a total of 45 Gy, After 3 month s, her headaches and facial pressure had fully resolved, but the right midfacial numbn ess, although diminished, persisted. However, at the 6-month follow-up, the facial numbn ess had completely resolved and she was entirely asy mptomatic, and she rem ained so at 18 month s.
Discussion
The original case serie s of cranial and intracranial invol vement in multiple myeloma was published by Clarke in 1954. 23 He cla ssified his series of 25 cases into one of three categories: syndromes ofcranial nerve palsies, intra cranial tumor syndromes, and intraorbital tumor syndromes. The first group included all multiple myelomas or pla sma cytomas that had invaded the skull base. Some of the affec ted patients were asymptomatic, while others had cranial nerve deficits.The cranial nerve most commonly affec ted was the abducens nerve, follo wed by the vestibulocochl ear nerv e and the trigeminal nerve. Our patient had facial numbness Plasmacytomas of the sinuses , nasopharynx, and skull base are gen erally large at the time of diagnosis." MRI is the ima gin g modality of choice for definin g the soft-tissue extent of the tumor,":" Plasmacytomas exhibit a low to interm ediate signal intensity on Tl-weighted imag ing and a moderate to high signal intensity on T2-weighted imagin g." CT is also useful for assessing the bone of the skull base and for surgical planning.Il·22.26 Howe ver, it is impo rtant to remember that the radiographic appeara nce of extramedullary plasmacytoma is not specific on either A B Figure 4 . A: H&E stain of afo rmalin-fixed section ofthe biopsy specimen reveals respirato ry mucosa that contains a dense plasma cell infiltrate (original magnification x200). B: Immunostaining is diffusely positive fo r kappa light chains, a finding that is consistent with a plasma cell neoplasm (original magnification x200). Plasmacytomas are made up of abnormal plasma cells that exhibit monoclonal intracellular immunoglobulins.i" Histologic analys is of the tumor in our patient demo nstrated a dense infiltrate of plasma cells with vesicular chromatin and occasional small nucleoli. Immuno logic staining showed diffuse expression of monoclonal kappa light chains. Traditionally, histopathologic examination cannot disting uish multiple myeloma from extramedullary plasmacytoma. I I Recently,however, Kremer and colleagues used molecular and immunohistochemical techniques to show that extra medullary plasmacytoma and multiple myeloma are phenotypically distinct." They found that cycli n D I and the neural cell adhesion molecule CD56 are universally expressed in multiple myeloma and absent in nearly all extramedullary plasma cell infiltrates.l-"
Radiation therapy is the treatment of choice for plasmacytomas, as plasma cells are highly radiosensitive. r' :" A total of 30 to 50 Gy has been recommended in most series.v" In a rece nt series of 16 patients with extramedullary plasmacytoma; Chao and coworkers reported that radiotherapy resulted in a 100% local control rate both radiograp hically and clinically. 14 The media n dose in that series was 45 Gy, and the median length of follow -up was 66 months. Long-term oncologic surveillance is required for these patien ts.
Some authors have recom mended total or subtotal surgical resectio n in addition to radiotherapy.P'v? Other treatment options include adjuvant alkylating chemotherapy and surgical resection alone. 17There has also been 1 reported case of a cavernous sinus plasmacytoma that was successfully treated with gamma-knife radiosurgery.' Unfortunately, postradiation scans were not available to us in this case because the patient declined to undergo further imagi ng.
The role of surgery in most cases is now limited to biopsy. In the past, tumors of the sphenoid sinus and clivus have required invasive open procedures for diagnosis and treatme nt.v -" Traditional approac hes to the clivus have included transsphenoid, transtemporal, transfacia l, transpharyngeal, and transcranial routes , but these open techniques are associated with a high level of morbid ity." Less aggressive means of obtaining tissue are preferable with a disease process for which the treatment of choice is radiotherapy rather than further surgery." Please contact us for more info rmation or to set-u p a f ree demonst ration.
-If .. CT-guided needle biopsy is being increasingly used in the evaluation of skull base lesions. Ljung et al were able to perform aspiration cytology on 11 skull base lesions with CT guidance while avoiding injury to vital structures." One of these tumors was a plasmacytoma that had arisen from the sphenoid sinus.
Transnasal endoscopic management has also become more popular in recent years for accessing lesions of the sphenoid sinus and clivus." :" Technologic advances and a better understanding of sinonasal anatomy have resulted in excellent access and visualization of the sphenoclival region. The addition of image guidance with computerassisted navigation has increased surgical confidence in this complex area. In a series of 15 patients, Kingdom and DelGaudio used endoscopic techniques to successfully diagnose lesions of the sphenoid sinus, orbital apex, and clivus, and they observed no complications." Imageguided assistance was used in each case, and 2 of these lesions were plasmacytomas located in the clivus. In our case, transnasal endoscopy provided ready access to the sphenoid sinus and superb visualization of the smoothsurfaced soft-tissue mass that had entered the right sinus through the posterolateral wall.
Gather objective pat ho logy data rather th an relying on yo ur patien t' s narrative; evaluate pr e-and postprocedu re diagn oses and treatment results; obtain reproduc ible docum entation of your procedures for more efficient reimbur sem ent sub mitt als; and offer new services to patients that strengthe n your practice.
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